Park Medi World Ltd – Fundamental Analysis

by

Stock Analysis Report: Park Medi World Ltd.

Date: January 28, 2026

Current Market Price (CMP): ₹153 – ₹156

Market Cap: ₹6,650 Cr (Approx)

1️⃣ Business Model & Work

  • Core Business: Park Medi World ek prominent Multi-Super Specialty Hospital Chain hai jo primarily North India me operate karti hai. Ye company “Park Group of Hospitals” ke naam se jaani jaati hai.
  • Scale: Inke paas approx 3,000+ beds ki capacity hai across 14+ hospitals. Ye Haryana ki sabse badi private hospital chain maani jaati hai.
  • Strategy: Company “Cluster-Based Approach” use karti hai, jahan ye ek region me density badhate hain taaki operational efficiency bani rahe.
  • Specialties: Cardiac Sciences, Oncology (Cancer), Neurosciences, aur Orthopaedics inke main revenue drivers hain.
  • Revenue Mix:
    • In-Patient (IPD): ~80-85% (Hospital industry standard).
    • Out-Patient (OPD): ~15-20%.

2️⃣ Industry & Sector Analysis

  • Sector Status: Secular Growth (Defensive). Healthcare India me recession-proof sector hai. Rising income aur insurance penetration growth ko drive kar rahe hain.
  • Regional Focus: North India (Haryana, Punjab, Delhi NCR, Rajasthan) me density kam hai, jiska fayda organized players ko mil raha hai.
  • Competition:
    • Listed Peers: Medanta (Global Health), Max Healthcare, Fortis, Artemis Medicare.
    • Competitive Advantage: “Affordable Luxury” segment me kaam karna aur Tier-2/Tier-3 cities (Panipat, Karnal, Hisar) me strong pakad.

3️⃣ Latest Financial Performance (Consolidated)

Based on Latest Available Data (FY25 Annual + Recent Trends).

MetricFY 2025 (Annual)FY 2024 (YoY)Growth/Status
Revenue₹1,426 Cr₹1,263 Cr+12.9% 🔼 (Steady Growth)
Operating Profit (EBITDA)₹375 Cr₹312 Cr+20.0% 🔼
Net Profit (PAT)₹213 Cr₹153 Cr+39.0% 🔼 (Strong Bottomline)
EBITDA Margin %~26-27%~25%Improving
EPS (₹)₹5.55₹3.95Increasing
  • Financial Health:
    • Debtor Days (⚠️ Red Flag): ~161 Days. Ye industry average se high hai. Company ka paisa Govt schemes (Ayushman/ECHS) me atka ho sakta hai, jo cash flow ko affect karta hai.
    • Debt: Debt-to-Equity ~0.58x. Manageable levels par hai.
    • ROCE: ~20-21% (Healthy for capital intensive business).

4️⃣ Management & Shareholding (Latest Post-IPO Pattern)

  • Promoters:Gupta Family (Dr. Ajit Gupta) holds ~82.89%.
    • Note: SEBI rule ke mutabik inhein agle 3 saal me holding 75% tak lani hogi, jo future me supply pressure (OFS) create kar sakta hai.
  • FIIs: ~1.28% (New entry post listing).
  • DIIs (Mutual Funds): ~8.58% – 8.78%. (Kotak Mutual Fund aur others ne strong stake liya hai).
  • Management Quality: Experienced doctors run kar rahe hain. Recent acquisitions (Bathinda & Delhi) aggressive growth mindset dikhate hain.

5️⃣ Valuation (Latest Market Data)

  • Current PE Ratio: ~30x – 32x (Based on FY25/TTM Earnings).
  • Peer Comparison (Valuation Gap):
    • Max Healthcare: ~65x – 70x PE.
    • Apollo Hospitals: ~60x – 65x PE.
    • Medanta (Global Health): ~45x – 50x PE.
    • Park Medi World: ~30x PE par trade kar raha hai. Ye apne peers se significant discount par hai.
  • Reason for Discount: High geographic concentration (Haryana heavy) aur high debtor days (Receivables issue).

6️⃣ Future Growth Triggers (3–5 Years)

  • Capacity Expansion: Target to reach 5,000+ beds by 2028. (Currently ~3,000).
  • Recent Acquisitions (Jan 2026):
    • Krishna Super-Speciality Hospital (Bathinda): 250 Beds acquire kiye.
    • Febris Hospital (Delhi): Narela me acquisition.
    • Ye acquisitions FY26-27 ke revenue me immediately reflect honge.
  • Margin Expansion: Jaise-jaise occupancy badhegi, operating leverage se margins 28-29% tak ja sakte hain.

7️⃣ Present Situation (Current Outlook)

  • Stock Phase: Discovery & Consolidation. Listing ke baad stock stabilize ho raha hai.
  • Short-Term: Recent acquisitions ki news se positive momentum bana hua hai.
  • Long-Term: North India ka healthcare market grow kar raha hai aur Park Medi ek dominant regional player ban kar ubhar raha hai.

8️⃣ Risk & Red Flags (⚠️ Important)

  1. High Receivables (Debtor Days ~161): Agar paisa collect karne me deri hoti hai, to working capital fasta hai. Ye primary concern hai.
  2. Geographic Concentration: Revenue ka bada hissa sirf Haryana aur NCR se aata hai. Diversification abhi kam hai.
  3. Promoter Dilution Risk: Promoters ke paas 82% stake hai. Future me unhein 7-8% stake bechna padega, jisse market me supply aayegi.

9️⃣ Final Verdict

  • Summary: Park Medi World ek High-Growth Regional Champion hai jo abhi valuation gap (Sasta) offer kar raha hai compared to giants like Max & Apollo. Financials strong hain (20% ROCE), lekin receivables (udhaari) ka issue monitor karna zaroori hai.
  • Investment Suitability:
    • Conservative Investors: ⏳ WAIT. High debtor days aur limited listing history ke karan volatility reh sakti hai.
    • Aggressive Investors: ✅ BUY for Long Term. 30x PE par healthcare stock milna rare hai. Agar company expansion execute kar leti hai, to ye re-rating candidate (30 PE ➝ 45 PE) ban sakta hai.
  • Approx Target Range (1 Year): ₹190 – ₹210 (Based on 35x PE & Earnings Growth).

Disclaimer: Ye article sirf educational purpose ke liye hai. Kisi bhi nivesh se pehle apne Financial Advisor se salah zarur lein.

Leave a Comment